article thumbnail

Breakthrough Research Identifies Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer

DAIC

The risk factors for postoperative embolism included Black race, interstitial fibrosis, advanced-stage disease requiring bilobectomy or pneumonectomy, and increased operative duration. occurrence of postoperative PE in patients undergoing a first-time pulmonary resection for lung cancer. occurrence of postoperative VTE and a 1.3%

Cancer 116
article thumbnail

Novartis Reclaims Anthos, Reenters Factor XI Race

CardiacWire

Anthos LILAC trial is focused on preventing stroke and systemic embolism in AFib patients, while ASTER and MAGNOLIA aim to use abelacimab to address VTE and GI cancer. Novartis abelacimab efforts will now take a unique clinical approach since the Anthos-designed phase 3 trials focus on more than just ischemic stroke.

AFIB 102
article thumbnail

Research progress on the association between lung cancer and pulmonary embolism

Journal of Cardiothoracic Surgery

Pulmonary embolism (PE), a form of venous thromboembolism, is a frequently observed complication in malignancies, with a notably high incidence in individuals with lung cancer. The presence of PE markedly redu.

article thumbnail

API-CAT: Extended Anticoagulant Therapy With Reduced-Dose Apixaban Noninferior to Full-Dose in Patients With Active Cancer and VTE

American College of Cardiology

Extended anticoagulant therapy with a reduced-dose of apixaban was noninferior to extended therapy with a full-dose of apixaban in preventing recurrent venous thromboembolism (VTE) in patients with active cancer and proximal deep-vein thrombosis or pulmonary embolism, based on findings from the API-CAT trial presented at ACC.25

Cancer 71
article thumbnail

Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?

NEJM Journal Watch - Cardiology

Among patients with low-risk pulmonary embolism, 18 months of anticoagulation significantly reduced its recurrence, compared with 6 months of treatment.

article thumbnail

Upper extremity phlegmasia cerulea dolens complicating supra vena cava embolism in a cervical cancer patient: case report

Frontiers in Cardiovascular Medicine

We herein present a rare upper extremity PCD case accompanied with supra vena cava and pulmonary embolism in a cervical cancer patient, who presented to our institution with severe pain, edema and irreversible venous gangrene of right upper limb with no response to anticoagulation therapy.

article thumbnail

Antithrombotic strategy in cancer patients comorbid with acute coronary syndrome and atrial fibrillation

Frontiers in Cardiovascular Medicine

It has been shown that patients with cancer have a longer expected life duration, benefiting from advanced medical therapy. A growing number of studies have elucidated the association between cancer and CVD. Moreover, different types of cancer have distinct risks, which may increase the complexity of antithrombotic therapy.